Therapeutic Inertia in an Insured Population with Type 2 Diabetes in the United States: A Retrospective Cohort Study
Over 50% of adults diagnosed with T2D were untreated with an AHA in the first year post diagnosis, and most of those who went untreated the first year remained untreated after 5 years. Among the delayed treatment patients, the majority did not use additional AHA classes besides their index therapy in the post-period. These findings suggest that therapeutic inertia affects a significant percentage of individuals with T2D. Given the untreated group's significantly worse cardiovascular outcomes and higher medical costs, these findings highlight a potential unmet need in the years immediately following T2D diagnosis.
Authors
- Maureen J. Lage (ORCID: https://orcid.org/0000-0003-4961-2027)
- Kristina Secnik Boye (ORCID: https://orcid.org/0000-0002-5953-5929)
- Vivian T. Thieu (ORCID: https://orcid.org/0000-0001-9803-4134)
- Kendra A. Terrell (ORCID: https://orcid.org/0009-0008-0915-3982)
Institutions
- Eli Lilly (United States) (US)
- Health Outcomes Solutions (United States) (US)
Publication Details
- Journal
- Diabetes Therapy
- Published
- 2025-09-08
- DOI
- https://doi.org/10.1007/s13300-025-01793-w
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00